What is the reason for poor outcome of antepartum immunoprophylaxis of hepatitis B immunoglobulin in prevention of vertical hepatitis B transmission?

Hepatitis Monthly

Volumn 7, Issue 3, 2007, Pages 163-165

  Alavian, Seyed Moayed ^a,b   Behnava, Bita ^b  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Tehran Hepatitis Center   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B VACCINE;

ANTEPARTUM IMMUNOPROPHYLAXIS; CHRONIC HEPATITIS; CLINICAL OUTCOME; HEPATITIS B; HUMAN; IMMUNOPROPHYLAXIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MORTALITY; NOTE; VIRUS TRANSMISSION;

EID: 84983064322     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: None     Document Type: Note

References (23)

1. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004; 11: 97-107.
2. Toukan A. Middle East Regional Study Group. Strategy for the control of hepatitis B virus infection in the middle East and North Africa. Vaccine 1990; Suppl 8: S117-S21.
3. Stevens CE, Neurath RA, Beasley RP, Szmuness W. HBeAg and anti-HBs detection by radio-immunoassay: correlation with vertical transmission of hepatitis B virus in Taiwan. J Med Virol 1979; 3: 237-93.
4. Edmunds WJ, Medley GF, Nokes DJ, O’Callaghan CJ, Whittle HC, Hall AJ. Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areas. Epidemiol Infect 1996; 117: 313-25.
5. Vildozola H. Vaccination against Hepatitis B: 20 years later. Rev Gastroenterol Peru 2007; 27: 57-66.
6. Adibi P, Ghassemian R, Alavian SM. Effectiveness of hepatitis B vaccination in children of chronic hepatitis B mothers. Saudi Med J 2004; 25: 1414-18.
7. Kabir A, Alavian SM, Ahanchi N, Malekzadeh R. Combined passive and active immunoprophylaxis for preventing perinatal transmission of the hepatitis B virus in infants born to HBsAg positive mothers in comparison with vaccine alone. Hepatol Res 2006; 36: 265-71.
8. Xiao XM, Li AZ, Zhu YK, Miao J. Prevention of vertical hepatitis B transmission by hepatitis B immunoglobulin in the third trimester of pregnancy. Int J Gynaecol Obstet 2007; 96: 167-70.
9. Ranger-Rogez S, Denis F. Hepatitis B mother--to--child transmission. Expert Rev Anti Infect Ther 2004; 2: 133-45.
10. Xiao-Mao L. Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection. World J Gastroenterol 2004; 21: 3215-7.
11. Yuan J, Lin J, Xu A, Li H, Hu B, Chen J, et al. Antepartum immunoprophylaxis of three doses of hepatitis B immunoglobulin is not effective: a single-centre randomized study. J Viral Hepat 2006; 13: 597-604.
12. Ngui SL, Andrews NJ, Underhill GS, Heptonstall J, Teo CG. Failed postnatal immunoprophylaxis for hepatitis B: characteristics of maternal hepatitis B virus as risk factor. Clin Infect Dis 1998; 27: 100-6.
13. Li XM, Yang YB, Hou HY, Shi ZJ, Shen HM, Teng BO, et al. Interruption of HBV intrauterine transmission: A clinical study. World J Gastroenterol 2003; 9: 1501-3.
14. Poovorawan Y, Chongsrisawat V, Theamboonlers A, Vimolkej L, Yano M. Is there evidence for intrauterine HBV infection in newborns of hepatitis B carrier mothers? Southeast Asian J Trop Med Public Health 1997; 28: 365-9.
15. Rumi MA, Begum K, Hassan MS, Hasan SM, Azam MG, Hasan KM, et al. Detection of hepatitis B surface antigen in pregnant women attending a public hospital for delivery: implication for vaccination strategy in Bangladesh. Am J Trop Med Hyg 1998; 59: 318-22.
16. Poovorawan Y, Sanpavat S, Pongpunglert W, Chumdermpadetsuk S, Sentrakul P, Vandepapeliere P, et al. Long term efficacy of hepatitis B vaccine in infants born to hepatitis Be antigen-positive mothers. Pediatr Infect Dis J 1992; 11: 816-21.
17. Tang JR, Hsu HY, Lin HH, Ni YH, Chang MH. Hepatitis B surface antigenemia at birth: a long-term follow-up study. J Pediatr 1998; 133: 374-7.
18. Hieu NT, Kim KH, Janowicz Z, Timmermans I. Comparative efficacy, safety and immunogenicity of Hepavax-Gene and Engerix-B, recombinant hepatitis B vaccines, in infants born to HBsAg and HBeAg positive mothers in Vietnam: an assessment at 2 years. Vaccine 2002; 20: 1803-8.
19. Noto H, Terao T, Ryou S, Hirose Y, Yoshida T, Ookubo H, et al. Special Committee for Preventing Hepatitis B in Shizuoka. Combined passive and active immunoprophylaxis for preventing perinatal transmission of the hepatitis B virus carrier state in Shizuoka, Japan during 1980-1994. J Gastroenterol Hepatol 2003; 18: 943-9.
20. Zhu Q, Lu Q, Gu X, Xu H, Duan S. A preliminary study on interruption of HBV transmission in uterus. Chin Med J (Engl) 1997; 110: 145-7.
21. Li C. Clinical observation on interruption of intrauterine transmission of HBV by HBIG. Chin J Clin Hepatol 2004; 20: 196.
22. Poland GA, Jacobson RM. Clinical practice: prevention of hepatitis B with the hepatitis B vaccine. N Engl J Med 2004; 351: 2832-8.
23. van Zonneveld M, van Nunen AB, Niesters HG, de Man RA, Schalm SW, Janssen HL. Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection. J Viral Hepat 2003; 10: 294-7.